Post-Transplant Lymphoproliferative Disease – PTLD

doi 10.5772/28891
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Single-Center Analysis of Post-Transplant Lymphoproliferative Disorder (Ptld) Outcomes With Epstein Barr Virus (Ebv) Assessments

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcomes in Pediatric Patients With Post-Transplant Lymphoproliferative Disorder (PTLD): Analysis of a 20-Year Single-Institutional Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Management of Post-Transplant Lymphoproliferative Disorders

British Journal of Haematology
Hematology
2018English

Baseline Differential Blood Count and Prognosis in CD20-positive Post-Transplant Lymphoproliferative Disorder in the Prospective PTLD-1 Trial

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

How Should We Treat Early Post-Transplant Lymphoproliferative Disease After Heart Transplantation?

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

The Influence of Tumor Immune Microenvironment and Tumor Immunity on the Pathogenesis, Treatment and Prognosis of Post-Transplant Lymphoproliferative Disorders (Ptld)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Mutational Landscape of B-Cell Post-Transplant Lymphoproliferative Disorders

British Journal of Haematology
Hematology
2017English

Impact of Post-Transplant Lymphoproliferative Disorder Subtype on Survival

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Cancer Risk Following Post-Transplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients

British Journal of Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy